oral PARP1-selective polymerase inhibitor
oral efficacy in BRCA1 mutant xenograft
from scaffold hopping from lit. PARP1/2 inh.
Bioorg. Med. Chem., Oct. 6, 2020
Lupin Ltd., Pune, IN
“compound 34” (Lupid oral in vivo PARP1-selective polymerase inhibitor)